Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 16515
Country/Region: Zimbabwe
Year: 2017
Main Partner: University of Washington
Main Partner Program: I-TECH
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $15,491,163 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,534,619
Care: TB/HIV (HVTB) $1,476,802
Care: Pediatric Care and Support (PDCS) $131,920
Strategic Information (HVSI) $42,184
Health Systems Strengthening (OHSS) $141,900
Testing: HIV Testing and Counseling (HVCT) $4,489,728
Sexual Prevention: Other Sexual Prevention (HVOP) $55,733
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $83,163
Treatment: Adult Treatment (HTXS) $5,535,114
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 796,359
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 459,377
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2018 6,865
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 1,784
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 1,784
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 962
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 1,125
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 962
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 1,125
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 11,804
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 10,753
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 1,446
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 1,455
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 461
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 851
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 461
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 851
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 7,386
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 5,529
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 864
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 875
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2018 1,277
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2018 1,641
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2018 1,277
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2018 1,642
HTS_TST Service Delivery Point (Community) Other: 25-49, Female, Negative 2018 17,452
HTS_TST Service Delivery Point (Community) Other: 25-49, Male, Negative 2018 15,418
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2018 2,117
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2018 2,132
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 17,482
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 27,271
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 45,191
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 6,666
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 1,780
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1,780
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 934
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 1,093
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 934
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 1,093
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 11,777
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 10,978
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 1,436
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 1,447
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 13,124
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 47,118
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 12,420
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 12,378
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 17,027
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 20,183
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 18,143
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 20,383
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 197,190
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 184,576
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 25,149
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 25,295
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 6,866
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 1,780
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 538
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 8,325
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 9,738
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 8,317
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 9,670
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 98,189
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 92,217
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 12,460
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 12,450
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 910
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 363
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 443
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 362
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 443
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 4,740
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 4,486
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 567
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 569
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 90
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 42,609
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 65
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 36,659
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 55
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 43,841
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 65
HTS_TST Sum of Test Result disaggregates 2018 71,444
HTS_TST Sum of Test Result disaggregates 2018 60,193
HTS_TST_POS By Test Result: Positive 2018 71,444
HTS_TST_POS By Test Result: Positive 2018 60,193
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2018 211
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2018 56
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 414
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2018 483
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 414
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 483
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 5,129
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 4,537
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 618
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 638
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 51
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 94
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 51
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 93
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 821
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 614
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 96
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 97
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2018 146
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2018 186
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2018 146
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2018 186
HTS_TST_POS Service Delivery Point (Community) Other: 25-49, Female, Positive 2018 1,935
HTS_TST_POS Service Delivery Point (Community) Other: 25-49, Male, Positive 2018 1,706
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Female, Positive 2018 236
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2018 238
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 1,189
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 1,808
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 2,918
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 169
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 386
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 461
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 386
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 461
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 5,103
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 4,753
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 596
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 601
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 376
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 1,408
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 470
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 464
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 1,885
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 2,189
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 1,915
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 2,204
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 21,916
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 20,617
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 2,757
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 2,775
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 169
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 905
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 1,052
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 903
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 1,090
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 10,924
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 10,233
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 1,369
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 1,374
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 370
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 447
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 369
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 446
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 4,746
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 4,441
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 569
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 571
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 400
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 341
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 507
PMTCT_ART Already on ART at beginning of current pregnancy 2018 7,587
PMTCT_ART New on ART 2018 6,194
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 13,781
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 103,834
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 12,533
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 3,585
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 388
PMTCT_EID Unknown, <= 2 months 2018 7,502
PMTCT_EID Unknown, 2 - 12 months 2018 1,058
PMTCT_STAT By Age (Numerator): : 15-19 2018 20,377
PMTCT_STAT By Age (Numerator): 10-14 2018 3
PMTCT_STAT By Age (Numerator): 20-24 2018 31,910
PMTCT_STAT By Age (Numerator): 25-49 2018 51,652
PMTCT_STAT By known positives: 15-19 2018 1,511
PMTCT_STAT By known positives: 20-24 2018 2,363
PMTCT_STAT By known positives: 25-49 2018 3,817
PMTCT_STAT By new negatives: 15-19 2018 17,563
PMTCT_STAT By new negatives: 20-24 2018 27,519
PMTCT_STAT By new negatives: 25-49 2018 44,547
PMTCT_STAT By new positives: 15-19 2018 1,303
PMTCT_STAT By new positives: 20-24 2018 2,022
PMTCT_STAT By new positives: 25-49 2018 3,284
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 103,834
PMTCT_STAT_den By Age (Denominator): 10-14 2018 80
PMTCT_STAT_den By Age (Denominator): 15-19 2018 20,953
PMTCT_STAT_den By Age (Denominator): 20-24 2018 32,820
PMTCT_STAT_den By Age (Denominator): 25-49 2018 52,962
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 61
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,765
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 108
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2,669
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 6,783
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 4,492
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 111
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2,651
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 192
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3,998
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 87
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,482
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 161
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 8
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 3,783
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 5
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 6,444
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 13
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 7,501
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 100
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,913
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 189
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,477
TX_CURR Age/Sex: <1 2018 1,183
TX_CURR Age/Sex: 1-9 2018 13,669
TX_CURR Age/Sex: 10-14 Female 2018 4,782
TX_CURR Age/Sex: 10-14 Male 2018 4,649
TX_CURR Age/Sex: 15-19 Female 2018 7,561
TX_CURR Age/Sex: 15-19 Female 2018 3,226
TX_CURR Age/Sex: 15-19 Male 2018 4,340
TX_CURR Age/Sex: 15-19 Male 2018 1,827
TX_CURR Age/Sex: 20-24 Female 2018 22,082
TX_CURR Age/Sex: 20-24 Female 2018 9,347
TX_CURR Age/Sex: 20-24 Male 2018 7,855
TX_CURR Age/Sex: 20-24 Male 2018 3,236
TX_CURR Age/Sex: 25-49 Female 2018 118,475
TX_CURR Age/Sex: 25-49 Female 2018 52,587
TX_CURR Age/Sex: 25-49 Male 2018 68,209
TX_CURR Age/Sex: 25-49 Male 2018 29,491
TX_CURR Age/Sex: 50+ Female 2018 21,095
TX_CURR Age/Sex: 50+ Female 2018 9,052
TX_CURR Age/Sex: 50+ Male 2018 19,960
TX_CURR Age/Sex: 50+ Male 2018 8,572
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 293,360
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 117,338
TX_CURR Sum of age/sex disaggregates 2018 5,053
TX_CURR Sum of Age/Sex disaggregations 2018 11,901
TX_NEW Breastfeeding status 2018 689
TX_NEW By Age/Sex: <1 2018 265
TX_NEW By Age/Sex: 1-9 2018 1,443
TX_NEW By Age/Sex: 10-14 Female 2018 731
TX_NEW By Age/Sex: 10-14 Male 2018 731
TX_NEW By Age/Sex: 15-19 Female 2018 2,158
TX_NEW By Age/Sex: 15-19 Female 2018 2,096
TX_NEW By Age/Sex: 15-19 Male 2018 2,555
TX_NEW By Age/Sex: 15-19 Male 2018 2,538
TX_NEW By Age/Sex: 20-24 Female 2018 2,579
TX_NEW By Age/Sex: 20-24 Female 2018 2,096
TX_NEW By Age/Sex: 20-24 Male 2018 2,928
TX_NEW By Age/Sex: 20-24 Male 2018 2,538
TX_NEW By Age/Sex: 25-49 Female 2018 24,796
TX_NEW By Age/Sex: 25-49 Female 2018 26,980
TX_NEW By Age/Sex: 25-49 Male 2018 24,788
TX_NEW By Age/Sex: 25-49 Male 2018 23,063
TX_NEW By Age/Sex: 50+ Female 2018 3,021
TX_NEW By Age/Sex: 50+ Female 2018 3,208
TX_NEW By Age/Sex: 50+ Male 2018 3,035
TX_NEW By Age/Sex: 50+ Male 2018 3,229
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 69,084
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 65,748
TX_NEW Pregnancy status 2018 6,091
TX_NEW Sum of Age/Sex disaggregates 2018 67,322
TX_NEW Sum of Age/Sex disaggregates 2018 65,748
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 335,479
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 2,805
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 302,473
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 8,093
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 894
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 8,229
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1,050
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 161,830
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 17,841
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 94,085
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 10,455
TX_PVLS Numerator: Indication: Routine 2018 272,233
TX_PVLS Numerator: Indication: Targeted 2018 30,240
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 532
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 34
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 4,940
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 530
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 9,001
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 38
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 999
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 4
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 13,418
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 944
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1,490
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 105
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 175,975
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 42
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 19,550
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 104,774
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 564
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 11,647
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 63
TX_PVLS_den Denominator: Indication: Routine 2018 302,480
TX_PVLS_den Denominator: Indication: Routine 2018 2,523
TX_PVLS_den Denominator: Indication: Targeted 2018 33,610
TX_PVLS_den Denominator: Indication: Targeted 2018 281
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 594
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 3
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 37
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 5,481
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 31
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 592
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 3
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8,983
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,907
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 179,057
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 104,551
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 223
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 248
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,982
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 10,163
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 199,789
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 116,258
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 335,450
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 33,534
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 994
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 19,961
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 988
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 11,591
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 9,956
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 199,629
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 9,915
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 115,857
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 7,982
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 7,982
TX_TB_den Denominator: By Screen Result: Negative 2018 318,678
TX_TB_den Denominator: By Screen Result: Positive 2018 16,773
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 15,937
Cross Cutting Budget Categories and Known Amounts Total: $1,826,211
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Key Populations: MSM and TG $100,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Training of health workers and community outreach workers
Food and Nutrition: Policy, Tools, and Service Delivery $316,866
Human Resources for Health $959,345
Water $50,000